Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07083193
What this trial is testing

AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Accro Bioscience (Suzhou) Limited 24
Not applicableUnknownNCT05151458
What this trial is testing

Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
Assiut University 80
Large-scale testing (Phase 3)Study completedNCT00297648
What this trial is testing

Mucosal Healing Study in Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
UCB Pharma 89
Not applicableTemporarily pausedNCT05450133
What this trial is testing

Hematological Parameters in Axial Spondyloarthritis

Who this might be right for
Ankylosing Spondylitis
Bozyaka Training and Research Hospital 300
Large-scale testing (Phase 3)Enrolling By InvitationNCT05979441
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
MyositisActive Idiopathic Inflammatory MyopathyDermatomyositis+3 more
argenx 240
Large-scale testing (Phase 3)Study completedNCT01369342
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Who this might be right for
Crohn's DiseaseInflammatory Bowel DiseaseIBD+1 more
Janssen Research & Development, LLC 640
Testing effectiveness (Phase 2)Study completedNCT02378688
What this trial is testing

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 78
Large-scale testing (Phase 3)Study completedNCT02096861
What this trial is testing

Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Celltrion 220
Large-scale testing (Phase 3)Study completedNCT03464136
What this trial is testing

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

Who this might be right for
Crohn Disease
Janssen Scientific Affairs, LLC 386
Testing effectiveness (Phase 2)Study completedNCT00001934
What this trial is testing

Zenapax to Treat Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 22
Not applicableNot Yet RecruitingNCT07356232
What this trial is testing

Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease, Active
University of Pennsylvania 80
Testing effectiveness (Phase 2)Ended earlyNCT03850509
What this trial is testing

Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation

Who this might be right for
Crohn's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT03269695
What this trial is testing

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Who this might be right for
Ulcerative Colitis
Pfizer 20
Not applicableStudy completedNCT01534312
What this trial is testing

Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)

Who this might be right for
Colitis, UlcerativeInflammatory Bowel Diseases
University of Aarhus 24
Post-approval studies (Phase 4)Looking for participantsNCT05928039
What this trial is testing

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

Who this might be right for
Crohn Disease
University of Calgary 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242471
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 703
Not applicableStudy completedNCT02063880
What this trial is testing

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

Who this might be right for
Human Immunodeficiency VirusImmune Reconstitution Inflammatory Syndrome
University of Washington 183
Large-scale testing (Phase 3)Looking for participantsNCT07577856
What this trial is testing

JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 644
Testing effectiveness (Phase 2)Ended earlyNCT03201445
What this trial is testing

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Disease
Lakefront Biotherapeutics NV 139
Large-scale testing (Phase 3)Study completedNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Next Page